Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
2004 National Healthcare Quality Report

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Table 2.32: Percent of patients who experienced ventilator exposure with ventilator-associated pneumonia (VAP) events, United States, 2002

Population group Exposed Adverse events Percent of exposed with eventa Standard errora
Total 1,061 95 7.9 1.063
Age        
    0-64 161 13 7.8 2.484
    65-74 376 36 9.9 2.084
    75-84 392 35 7.7 1.819
    85 and over 132 11 4 1.543
Gender        
    Male 571 58 9.8 1.667
    Female 490 37 5.8 1.164
Race        
    Black 113 11 11.4 3.532
    Other 56 5 5.2 2.81
    White 892 79 7.5 1.122
Diabetes        
    No 648 59 8.3 1.471
    Yes 413 36 7.3 1.646
CHF/Pulmonary Edema        
    No 424 34 7.9 1.826
    Yes 637 61 7.9 1.379
COPD        
    No 511 47 7.9 1.063
    Yes 550 48 6.6 1.318
Smoking        
    No 803 68 7.8 1.21
    Yes 258 27 8.3 2.102
Steroids        
    No 927 86 8.2 1.167
    Yes 134 9 5.7 2.301

a Percent and standard error based on weighted data.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease.

Source: Centers for Medicare and Medicaid Services, Medicare Patient Safety Monitoring System.

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care